As of Nov 25
| +0.14 / +2.41%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 26.25, with a high estimate of 26.25 and a low estimate of 26.25. The median estimate represents a +341.92% increase from the last price of 5.94.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.